tiprankstipranks
Trending News
More News >
Infinity Pharmaceuticals (INFIQ)
OTHER OTC:INFIQ
US Market

Infinity Pharmaceuticals (INFIQ) Income Statement

Compare
914 Followers

Infinity Pharmaceuticals Income Statement

Last quarter (Q2 2023), Infinity Pharmaceuticals's total revenue was $583.00K, a decrease of -20.25% from previous quarter. In Q2, Infinity Pharmaceuticals's net income was $-9.96M. See Infinity Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.59M$ 1.86M$ 1.72M$ 3.05M
Gross Profit
$ 1.03M$ 738.00K$ 682.00K$ -4.26M
Operating Expenses
$ 45.87M$ 45.82M$ 39.18M$ 41.41M
Depreciation and Amortization
$ 458.00K$ 480.00K$ 483.00K$ 219.00K
EBITDA
$ -43.73M$ -44.60M$ -37.56M$ -44.33M
Operating Income
$ -44.84M$ -45.08M$ -38.50M$ -45.66M
Other Income/Expenses
$ 475.00K$ -179.00K$ -2.00M$ -1.45M
Pretax Income
$ -44.37M$ -45.26M$ -40.49M$ -47.11M
Net Income
$ -44.37M$ -45.26M$ -40.49M$ -47.06M
Per Share Metrics
Basic EPS
$ -0.50$ -0.53$ -0.68$ -0.83
Diluted EPS
$ -0.50$ -0.53$ -0.68$ -0.83
Weighted Average Shares Outstanding
89.25M 85.60M 59.86M 56.98M
Weighted Average Shares Outstanding (Diluted)
89.25M 85.60M 59.86M 56.98M
Currency in USD

Infinity Pharmaceuticals Earnings and Revenue History